99 related articles for article (PubMed ID: 8276291)
1. A retrospective evaluation of activity of gemcitabine/platinum regimens in the treatment of recurrent ovarian cancer.
Le TN; Harvey RE; Kim CK; Brown J; Coleman RL; Smith JA
Gynecol Oncol Res Pract; 2017; 4():16. PubMed ID: 29158911
[TBL] [Abstract][Full Text] [Related]
2. Reducing renal function assessment prior to platinum-based chemotherapy: a real-world evaluation.
Van der Gaag S; Labots M; Swart EL; Crul M
Acta Oncol; 2024 Apr; 63():169-174. PubMed ID: 38597664
[TBL] [Abstract][Full Text] [Related]
3. Plasma erythropoietin concentrations in patients receiving intensive platinum or nonplatinum chemotherapy.
Canaparo R; Casale F; Muntoni E; Zara GP; Della Pepa C; Berno E; Pons N; Fornari G; Eandi M
Br J Clin Pharmacol; 2000 Aug; 50(2):146-53. PubMed ID: 10930966
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics-A Review.
Stankovic JSK; Selakovic D; Mihailovic V; Rosic G
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092125
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients.
Nitz A; Kontopantelis E; Bielack S; Koscielniak E; Klingebiel T; Langer T; Paulides M
Oncol Lett; 2013 Jan; 5(1):311-315. PubMed ID: 23255940
[TBL] [Abstract][Full Text] [Related]
6. Ocular toxicity following carboplatin chemotherapy for neuroendocrine tumour of the bladder.
Ng J; Sadiq M; Mansoor Q
J Oncol Pharm Pract; 2023 Apr; 29(3):768-771. PubMed ID: 36000302
[TBL] [Abstract][Full Text] [Related]
7. Dietary Magnesium Replacement for Prevention of Hypomagnesemia in Patients With Ovarian Cancer Receiving Carboplatin-Based Chemotherapy.
Liu W; Meyer L; Morse M; Li Y; Song J; Engle R; Lopez G; Narayanan S; Soliman PT; Ramondetta L; Bruera E; Cohen L
JCO Oncol Pract; 2024 Apr; 20(4):517-524. PubMed ID: 38301188
[TBL] [Abstract][Full Text] [Related]
8. H-Dot Mediated Nanotherapeutics Mitigate Systemic Toxicity of Platinum-Based Anticancer Drugs.
Yamashita A; Park SH; Zeng L; Stiles WR; Ahn S; Bao K; Kim J; Kang H; Choi HS
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895146
[TBL] [Abstract][Full Text] [Related]
9. Editorial: New strategies to overcome platinum resistance in ovarian cancer.
Wei JJ; Martinelli F
Front Oncol; 2024; 14():1390760. PubMed ID: 38549931
[No Abstract] [Full Text] [Related]
10. Self-care strategies to cope with taste changes after chemotherapy.
Rehwaldt M; Wickham R; Purl S; Tariman J; Blendowski C; Shott S; Lappe M
Oncol Nurs Forum; 2009 Mar; 36(2):E47-56. PubMed ID: 19273394
[TBL] [Abstract][Full Text] [Related]
11. [Importance of platinum dose intensity in treatment of epithelial ovarian cancer. Austrian Study Group for Therapy of Ovarian Cancer].
Sevelda P; Kurz C; Obermair A; Vavra N; Breitenecker G; Czerwenka K; Dittrich C; Salzer H
Wien Klin Wochenschr; 1993; 105(24):732-6. PubMed ID: 8116312
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
[TBL] [Abstract][Full Text] [Related]
13. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
14. High-dose cisplatin carboplatin chemotherapy in primary advanced epithelial ovarian cancer.
Fanning J; Hilgers RD
Gynecol Oncol; 1993 Nov; 51(2):182-6. PubMed ID: 8276291
[TBL] [Abstract][Full Text] [Related]
15. Combined cisplatin and carboplatin chemotherapy for treatment of advanced epithelial ovarian cancer.
Gershenson DM; Morris M; Burke TW; Levenback C; Kavanagh JJ; Fromm GL; Silva EG; Warner D; Wharton JT
Gynecol Oncol; 1995 Sep; 58(3):349-55. PubMed ID: 7672700
[TBL] [Abstract][Full Text] [Related]
16. Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer.
Shapiro JD; Rothenberg ML; Sarosy GA; Steinberg SM; Adamo DO; Reed E; Ozols RF; Kohn EC
Cancer; 1998 Nov; 83(9):1980-8. PubMed ID: 9806657
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
